Patents
Patents for C07C 311 - Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups (17,647)
03/2000
03/23/2000WO2000015204A2 Use of benzenesulfonyl(thio)ureas for the treatment and prophylaxis of dysfunctions of the autonomous nervous system and use of benzenesulfonyl(thio)ureas in combination with beta-receptor blockers
03/23/2000WO1999063983A9 MULTIBINDING AGENTS THAT MODULATE PPARη AND RXR RECEPTORS
03/23/2000DE19843301A1 Pulverförmige, modifizierte Füllstoffe enthaltende Kautschukpulver, Verfahren zu ihrer Herstellung und Verwendung Powdery, modified fillers containing rubber powder, process for their preparation and use
03/23/2000CA2343101A1 Benzene derivatives and medicinal use thereof
03/22/2000EP0987552A2 Diarylsulfonylurea binding proteins
03/22/2000CN1248244A N-arylsulfonamide- and pyrrolidinecarboxylic acid intermediates, and their use for preparation of herbicidal 1,3-dioxo-1H-pyrrolo [1,2-c] imidazole derivatives
03/22/2000CN1247863A Carriers for combination of organic synthetic connecting material, their prepn. and use
03/21/2000US6040339 Treatment and prophylaxis of hypercholesteremia or arteriosclerosis in a mammal
03/21/2000US6040338 N,n-bis(sulfonyl)hydrazines useful as antineoplastic agents
03/21/2000US6040317 Sulfonamide fibrinogen receptor antagonists
03/21/2000US6040274 2-Aroylcyclohexanediones, their preparation and their use as herbicides or plant growth-regulating agents
03/21/2000US6040126 Open chain a-carbonyl acetanilide yellow dye-forming coupler compound
03/16/2000WO2000014058A1 Novel color-developing compound and recording material
03/16/2000DE19841534A1 Treating autonomic nervous system dysfunction, especially vagal dysfunction of the heart, uses new or known benzenesulfonyl (thio)urea derivatives optionally in combination with beta-blockers
03/15/2000EP0985662A2 Linker binding carriers for organic synthesis, their production and use
03/15/2000EP0850232B1 Benzothiazolone derivatives
03/15/2000CN1247529A Sulfonamide and carboxamide derivatives and drugs containing same as active ingredient
03/14/2000US6037472 For treating disease-states characterized by excessive activity of matrix metalloproteases such as rheumatoid arthritis, osteoarthritis, periodontal disease, aberrant angiogenesis, tumor invasion and metastasis
03/14/2000US6037377 Antiinflammatory agents and antiallergens
03/14/2000US6037362 Carbazole derivatives; deprotecting, amination; antilipemic and antidiabetic agents; b-adrenaline receptor agonists; dietetics
03/14/2000US6036830 Desalination of aqueous sulphonamide solutions
03/10/2000CA2281490A1 Linker-bound carriers for organic synthesis, their production and use
03/09/2000WO2000012462A1 Aminoalcohol derivatives and their use as beta 3 adrenergic agonists
03/09/2000WO2000012077A1 Potassium channel inhibitors and method
03/09/2000WO2000012075A1 Nitrosated and nitrosylated alpha-adrenergic receptor antagonists, compositions and methods of use
03/09/2000DE19840108A1 Alpha-amino-cycloalkene preparation in quantitative yield by metathesis of amino-alkadiene, used as precursors for e.g. plant protectants, cyclohexylamine or sweeteners
03/09/2000CA2341458A1 Aminoalcohol derivatives and their use as beta 3 adrenergic agonists
03/09/2000CA2339145A1 Nitrosated and nitrosylated alpha-adrenergic receptor antagonists, compositions and methods of use
03/08/2000EP0983267A1 Amidoaromatic ring sulfonamide hydroxamic acid compounds
03/08/2000EP0983232A2 Guanidinylation reagents
03/08/2000EP0983228A1 Protease inhibitors
03/08/2000EP0983226A1 New nitromethyl ketones, process for preparing them and compositions containing them
03/08/2000EP0983216A1 Method for the synthesis of perfluorosulphonamides, perfluorosulphonamides and their salts, and a sulphonation reagent
03/07/2000US6034275 Tertiary amines
03/07/2000US6034242 2,4-pentadienoic acid derivatives having retinoid-like biological activity
03/07/2000US6034127 Amidino protease inhibitors
03/07/2000US6034104 Anticoagulant agents
03/07/2000CA2007935C Aromatic keto compounds, the preparation thereof, and drugs and cosmetics containing these
03/02/2000WO2000011742A1 Cyano-substituted methide and amide salts
03/02/2000WO2000010982A1 Quinazoline derivatives and pharmaceutical applications therof
03/02/2000WO2000010970A1 Methoximinophenylacetic acid amides
03/02/2000WO2000010969A1 Sulfonylimides and their use as conductive salts
03/02/2000CA2341357A1 Quinazoline derivatives and pharmaceutical applications therof
03/02/2000CA2340379A1 Cyano-substituted methide and amide salts
03/02/2000CA2339627A1 Sulfonylimides and their use as conductive salts
03/01/2000EP0981522A1 Process for synthesizing carbapenem intermediates
03/01/2000CN1246109A 5-aroylnaphthalene derivatives
03/01/2000CN1049888C Process for preparing benzoylguanidine
02/2000
02/29/2000US6030976 Use of sulfonamides
02/29/2000US6030946 Reversible cysteine protease inhibitors
02/29/2000CA2280049A1 Diarylsulfonylurea binding proteins
02/24/2000WO2000009116A1 Grp receptor ligands
02/24/2000WO1999064050A8 Novel potassium channel drugs and their uses
02/24/2000WO1999055687A3 Hydroxypropylamide peptidomimetics as inhibitors of aspartyl proteases
02/24/2000DE19925780A1 New 2-methoxyimino-2-phenyl-acetamide derivatives useful as microbicides, especially fungicides for plant protection
02/23/2000EP0980866A2 Phenyl heterocycles as cyclooxygenase-2 inhibitors
02/23/2000EP0980864A2 Sulphonamide derivatives
02/23/2000EP0980353A1 Fluorinated sulphonamide and sulphone derivatives
02/23/2000CN1245490A Sulfonyl urea derivatives and their use in control of interleukin-1 activity
02/23/2000CN1245486A Ketobenzamides as calpain inhibitors
02/22/2000US6028223 An integrin antagonists treating bone disorder, periodontal disease, osteoporosis, humoral hypercalcemia of malignancy, paget's disease, tumor angiogenesis, diabetic retinopathy, arthritis, smooth muscle cell migration and restenosis
02/22/2000US6028219 Process for the nitration of diphenylethers
02/22/2000US6028100 Dihalopropene compounds, insecticides containing them as active ingredients, and intermediates for their production
02/16/2000EP0979107A1 Light imaging contrast agents
02/16/2000EP0802900B1 Antiarrhythmic (s)-enantiomers of methanesulfonamides
02/16/2000CN1244859A Benzenesulfonamide derivatives and drugs containing the same
02/16/2000CN1049427C Recoverying device of ammonia from sulfanilamide by-product
02/16/2000CN1049333C Process for producing fine particulate materials
02/15/2000US6025472 N-substituted glycine derivatives as enzyme inhibitors
02/15/2000US6025177 Asymmetric grignard synthesis with cyclic 1,2 aminoalcohols
02/15/2000US6025147 Inhibitors of interleukin-1 β converting enzyme
02/15/2000CA2152792C Novel 3,4-diaryl thiophenes and analogs thereof having use as antiinflammatory agents
02/10/2000WO2000006658A2 Adhesives and sealants
02/10/2000WO2000006610A2 Polymer production
02/10/2000WO2000006561A1 Tricyclic sulfonamides and their derivatives as inhibitors of matrix metalloproteinases
02/10/2000WO2000006539A1 Alkenyl sulphonamide derivatives
02/10/2000WO2000006538A1 Methods of purifying lithium salts
02/10/2000WO2000006537A1 N-substituted sulfonamide derivatives
02/10/2000WO2000006529A1 Diketoacid-derivatives as inhibitors of polymerases
02/10/2000WO2000006157A1 Sulphonamide derivatives
02/10/2000WO2000006156A1 Amide, carbamate, and urea derivatives
02/10/2000WO2000006149A1 Sulfonamide derivatives
02/10/2000WO2000006148A1 Sulphonamide derivatives
02/10/2000WO2000006146A1 Substituted anilide compounds and methods
02/10/2000WO2000006137A2 Glucocorticoid-selective anti-inflammatory agents
02/10/2000WO2000006083A2 Sulfonamide derivatives
02/10/2000WO1999063944A3 Novel therapeutic agents that modulate estrogen receptors
02/10/2000CA2339099A1 Sulfonamide derivatives
02/10/2000CA2339091A1 Sulphonamide derivatives
02/10/2000CA2338994A1 Sulfonamide derivatives
02/10/2000CA2338916A1 Amide, carbamate, and urea derivatives
02/10/2000CA2338864A1 Sulphonamide derivatives
02/10/2000CA2338862A1 Alkenyl sulphonamide derivatives
02/10/2000CA2338764A1 Substituted anilide compounds and methods
02/10/2000CA2338490A1 Diketoacid-derivatives as inhibitors of polymerases
02/10/2000CA2335077A1 Tricyclic sulfonamides and their derivatives as inhibitors of matrix metalloproteinases
02/09/2000EP0977745A1 Thioaryl sulfonamide hydroxamic acid compounds
02/09/2000EP0977741A1 Substituted phenyl derivatives, their preparation and use
02/09/2000EP0977733A1 Arylsulfonylamino hydroxamic acid derivatives
02/09/2000EP0783487B1 2-aroylcyclohexandiones, process for preparing the same and their use as herbicides or plant growth regulators